BioSpace News Archive

Drug Development

Merrimack Pharmaceuticals Inc. Announces Oral Presentation Of Additional Analyses Of MM-398 Phase 3 NAPOLI-1 Study At The American Society of Clinical Oncology 2015 Gastrointestinal Cancers Symposium

January 8, 2015
·
3 min read
Business

Stemline Therapeutics, Inc. In-Licenses Novel Oral Small Molecule Nuclear Transport Inhibitor Targeting XPO1

January 8, 2015
·
4 min read
Biotech Bay

CAPNIA, Inc. Applies For Orphan Drug Designation In The U.S. For The Treatment Of Trigeminal Neuralgia

January 8, 2015
·
5 min read
Business

H&P Labs Announces In-Licensing Agreement With Harvard University For Compounds To Develop Oral Ebola Treatment

January 8, 2015
·
2 min read
Policy

ANSYS, Inc. SCADE Receives ISO 26262 Qualification

January 8, 2015
·
3 min read
Drug Development

Cleave Biosciences Initiates Phase 1 Clinical Trial Of CB-5083 In Patients With Advanced Solid Tumors

January 8, 2015
·
3 min read
Benitec Announces Publication Of Independent Research Supporting Tribetarna™ For Additional Cancer Indications

January 8, 2015
·
4 min read
Drug Development

CytRx Corporation Announces Positive Interim Phase 2 Aldoxorubicin Results As A Treatment For HIV-Related Kaposi’s Sarcoma (KS)

January 8, 2015
·
7 min read
Business

Musculoskeletal Transplant Foundation Signs Group Purchasing Agreement With Premier, Inc.

January 8, 2015
·
1 min read
Lone Star Bio

Lexicon Pharmaceuticals, Inc. To Present At The 33rd Annual J.P. Morgan Healthcare Conference

January 8, 2015
·
2 min read